Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?

ABSTRACT:

Background

The optimal properties of a comprehensive (level II) neuropsychological battery for determining Parkinson's disease mild cognitive impairment (PD-MCI) by Movement Disorder Society (MDS) Task Force criteria remain unresolved.

Methods

Seventy-six nondemented PD patients underwent PD-MCI classification using a consensus diagnosis and level II criteria. We examined the optimal number of tests in each of the five designated cognitive domains, identified the best tests within each domain, and determined the best overall battery for PD-MCI level II diagnosis.

Results

A battery with two tests per domain provided a highly practical, robust diagnostic assessment. Level II testing with the two best tests and impairment defined as 2 standard deviations below norms was

SUBMITTER: Goldman JG 

PROVIDER: S-EPMC4357536 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature